Skynor Medical Recognized as National-Level 'Specialized, Sophisticated, Distinctive, and Innovative' Little Giant Enterprise

On October 20, the Shanghai Municipal Commission of Economy and Informatization officially announced the recognition and re-examination results of the 2025 "Little Giant" enterprises specializing in new and specialized fields, organized and implemented by the Ministry of Industry and Information Technology.Skynor Medical (Shanghai) Co., Ltd. Successfully Selected as a "Little Giant" Enterprise in the Seventh Batch of Specialized, Refined, and Innovative Enterprises by China's Ministry of Industry and Information Technology.

National "Little Giant" enterprises with specialization and innovation are leaders among small and medium-sized enterprises (SMEs) with specialization, precision, uniqueness, and novelty. They represent the frontrunner companies in niche markets that focus on deep cultivation, demonstrate outstanding innovation capabilities, lead in market share, master key core technologies, and exhibit excellent quality and efficiency. This title holds high authority within China's SME evaluation system.

The evaluation of national-level specialized, refined, distinctive, and innovative "little giant" enterprises focuses on selecting high-quality companies that have long been active in specific niche fields and possess core advantages in specialization, refinement, distinctiveness, and innovation. These companies provide key products that address critical "bottleneck" issues in important areas, serving as a crucial pillar for promoting the high-quality development of China's manufacturing industry. Skynor Medical has stood out in fierce competition through its continuous R&D investment, deep technological accumulation, and significant clinical value in the field of neurovascular and peripheral vascular interventions. This honor not only represents high recognition of the company’s innovation capabilities and transformation capacity but also serves as authoritative acknowledgment of its leading role in advancing the development of China’s high-end medical device manufacturing industry.